E.F. Nash

4.1k total citations
66 papers, 998 citations indexed

About

E.F. Nash is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, E.F. Nash has authored 66 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in E.F. Nash's work include Cystic Fibrosis Research Advances (48 papers), Inhalation and Respiratory Drug Delivery (14 papers) and Tracheal and airway disorders (8 papers). E.F. Nash is often cited by papers focused on Cystic Fibrosis Research Advances (48 papers), Inhalation and Respiratory Drug Delivery (14 papers) and Tracheal and airway disorders (8 papers). E.F. Nash collaborates with scholars based in United Kingdom, Canada and United States. E.F. Nash's co-authors include Elizabeth Tullis, Anne L. Stephenson, Heather Boonstra, J.L. Whitehouse, Jennifer L. Taylor‐Cousar, Peter G. Middleton, Alan R Smyth, Félix Ratjen, Emma Helm and D. Honeybourne and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Journal of Hepatology and European Respiratory Journal.

In The Last Decade

E.F. Nash

60 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.F. Nash United Kingdom 18 633 156 140 104 75 66 998
Barry Linnane Ireland 17 1.3k 2.0× 156 1.0× 72 0.5× 206 2.0× 46 0.6× 72 1.5k
C. Etherington United Kingdom 19 806 1.3× 93 0.6× 60 0.4× 202 1.9× 96 1.3× 59 1.2k
Alex H. Gifford United States 19 1.1k 1.8× 339 2.2× 76 0.5× 147 1.4× 24 0.3× 60 1.5k
Marta García‐Clemente Spain 20 629 1.0× 144 0.9× 115 0.8× 225 2.2× 20 0.3× 100 1.3k
John Massie Australia 20 747 1.2× 55 0.4× 81 0.6× 290 2.8× 28 0.4× 67 1.2k
Gerry Hobbs United States 16 111 0.2× 84 0.5× 195 1.4× 63 0.6× 150 2.0× 50 1.0k
Leslie Hazle United States 5 1.3k 2.0× 189 1.2× 47 0.3× 291 2.8× 21 0.3× 6 1.5k
Lauren DiBiase United States 15 183 0.3× 167 1.1× 101 0.7× 227 2.2× 17 0.2× 66 815
Marco Mantero Italy 18 345 0.5× 74 0.5× 164 1.2× 496 4.8× 36 0.5× 63 1.2k
Roberto Buzzetti Italy 18 471 0.7× 41 0.3× 64 0.5× 336 3.2× 28 0.4× 41 964

Countries citing papers authored by E.F. Nash

Since Specialization
Citations

This map shows the geographic impact of E.F. Nash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.F. Nash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.F. Nash more than expected).

Fields of papers citing papers by E.F. Nash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.F. Nash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.F. Nash. The network helps show where E.F. Nash may publish in the future.

Co-authorship network of co-authors of E.F. Nash

This figure shows the co-authorship network connecting the top 25 collaborators of E.F. Nash. A scholar is included among the top collaborators of E.F. Nash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.F. Nash. E.F. Nash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nash, E.F., et al.. (2022). A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosis. Therapeutic Advances in Respiratory Disease. 16. 2663649461–2663649461. 12 indexed citations
2.
Zain, Nur Masirah M., Iain Stewart, Andrew Fogarty, et al.. (2022). Porphyromonas pasteri and Prevotella nanceiensis in the sputum microbiota are associated with increased decline in lung function in individuals with cystic fibrosis. Journal of Medical Microbiology. 71(2). 9 indexed citations
3.
Barrett, Joanne, et al.. (2021). Perception, experience and relationship with food and eating in adults with cystic fibrosis. Journal of Human Nutrition and Dietetics. 35(5). 757–764. 7 indexed citations
4.
Keyte, Rebecca, et al.. (2021). Exploring Associations Between Self-Compassion, Self-Criticism, Mental Health, and Quality of Life in Adults with Cystic Fibrosis: Informing Future Interventions. Journal of Clinical Psychology in Medical Settings. 29(2). 332–343. 10 indexed citations
5.
Egan, Helen, et al.. (2020). Mindfulness moderates the relationship between emotional eating and body mass index in a sample of people with cystic fibrosis. Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity. 26(5). 1521–1527. 26 indexed citations
6.
Kempegowda, Punith, et al.. (2020). Retinopathy and microalbuminuria are common microvascular complications in cystic fibrosis-related diabetes. Therapeutic Advances in Endocrinology and Metabolism. 11. 2389887004–2389887004. 11 indexed citations
7.
Taccetti, Giovanni, M. Denton, Diana Bilton, et al.. (2019). A critical review of definitions used to describe Pseudomonas aeruginosa microbiological status in patients with cystic fibrosis for application in clinical trials. Journal of Cystic Fibrosis. 19(1). 52–67. 8 indexed citations
8.
Hoo, Zhe Hui, Elizabeth Coates, Chin Maguire, et al.. (2018). Pragmatic criteria to define chronic pseudomonas aeruginosa infection among adults with cystic fibrosis. European Journal of Clinical Microbiology & Infectious Diseases. 37(11). 2219–2222. 3 indexed citations
9.
Rowbotham, Nicola J., Sherie Smith, Zoe Elliott, et al.. (2017). EPS1.9 Question CF: a James Lind Alliance Priority Setting Partnership in cystic fibrosis. Journal of Cystic Fibrosis. 16. S38–S38. 4 indexed citations
10.
Shaw, Karen, et al.. (2017). A prospective pilot study of home monitoring in adults with cystic fibrosis (HOME-CF): protocol for a randomised controlled trial. BMC Pulmonary Medicine. 17(1). 22–22. 17 indexed citations
11.
Barr, H., Miguel Cámara, David A. Barrett, et al.. (2017). Weight gain during acute treatment of an initial pulmonary exacerbation is associated with a longer interval to the next exacerbation in adults with cystic fibrosis. ERJ Open Research. 3(3). 57–2017. 1 indexed citations
12.
Barr, H., Nigel Halliday, David A. Barrett, et al.. (2016). Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study. Journal of Cystic Fibrosis. 16(2). 230–238. 29 indexed citations
13.
Barr, H., Nigel Halliday, Miguel Cámara, et al.. (2015). Pseudomonas aeruginosaquorum sensing molecules correlate with clinical status in cystic fibrosis. European Respiratory Journal. 46(4). 1046–1054. 85 indexed citations
14.
Bourke, Stephen, et al.. (2013). Employment in adults with cystic fibrosis. Occupational Medicine. 64(2). 87–94. 25 indexed citations
15.
Nash, E.F., Stewart Cameron, Paula Agostini, et al.. (2012). Microbial contamination of non-invasive ventilation devices used by adults with cystic fibrosis. Journal of Hospital Infection. 81(2). 104–108. 5 indexed citations
16.
Nash, E.F., Anne L. Stephenson, Emma Helm, et al.. (2011). Intussusception in Adults with Cystic Fibrosis: A Case Series with Review of the Literature. Digestive Diseases and Sciences. 56(12). 3695–3700. 17 indexed citations
17.
Nash, E.F. & Jens Wiebensohn. (2010). Formale Modellierung landwirtschaftlicher Standards mit RIF und OWL.. 117–120.
18.
Nash, E.F., Aman S. Coonar, Richard Kremer, et al.. (2010). Survival of Burkholderia cepacia sepsis following lung transplantation in recipients with cystic fibrosis. Transplant Infectious Disease. 12(6). 551–554. 26 indexed citations
19.
Nash, E.F., et al.. (2009). Prevalence of dyslipidemia in adults with cystic fibrosis. Journal of Cystic Fibrosis. 9(1). 24–28. 71 indexed citations
20.
Maçek, Milan, Alice Krebsová, E.F. Nash, et al.. (1997). Possible association of the allele status of the CS.7/ Hha I polymorphism 5′ of the CFTR gene with postnatal female survival. Human Genetics. 99(5). 565–572. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barry Linnane Breakdown of academic impact, for papers by C. Etherington Breakdown of academic impact, for papers by Alex H. Gifford Breakdown of academic impact, for papers by Marta García‐Clemente Breakdown of academic impact, for papers by John Massie Breakdown of academic impact, for papers by Gerry Hobbs Breakdown of academic impact, for papers by Leslie Hazle Breakdown of academic impact, for papers by Lauren DiBiase Breakdown of academic impact, for papers by Marco Mantero Breakdown of academic impact, for papers by Roberto Buzzetti
Rankless by CCL
2026